• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多柔比星处理后 HL-60 细胞系中环细胞周期蛋白 D1 的表达。

Expression of cyclin D1 after treatment with doxorubicin in the HL-60 cell line.

机构信息

Department of Histology and Embryology, Nicolaus Copernicus University in Torun Collegium Medicum in Bydgoszcz, Karlowicza 24, 85-092 Bydgoszcz, Poland.

出版信息

Cell Biol Int. 2014 Jul;38(7):857-67. doi: 10.1002/cbin.10290. Epub 2014 May 6.

DOI:10.1002/cbin.10290
PMID:24764322
Abstract

Increased levels of cyclin D1 and amplification of CCND1 gene occur in many types of cancers. We have followed the expression of cyclin D1 after treatment with doxorubicin with reference to cell death and other possible therapeutic implications. The effect of the treatment on the cell cycle, survival, intracellular level (flow cytometry), and intracellular localization of cyclin D1 (fluorescence microscopy) and expression of CCND1 (real-time RT-PCR) was investigated in HL-60 cells. An increase in the fluorescence intensity of cyclin D1 occurred after treatment with 0.15 and 0.3 μM doxorubicin. This tendency was confirmed by real-time RT-PCR. Expression of CCND1 in relation to the reference gene PBGD was increased in cells exposed to 0.15 μM doxorubicin. Concomitantly, some alterations in the regulation of the G0/G1, S, and G2/M checkpoints occurred, accompanied by changes in the polyploid fraction of the population. This was particularly evident at 0.3 μM doxorubicin, at which concentration the rate of cell death was also clearly higher. In conclusion, depending on the concentration used, alterations in cell death and the number of S, G2/M, and polyploid cells may correspond with cyclin D1 levels. This, in turn, may reflect an important role of the protein as one of the possible survival/point-of-no-return regulators dependent on its concentration, which seems especially plausible in the context of more prominent cell death in the above-mentioned fractions of cells.

摘要

cyclin D1 水平升高和 CCND1 基因扩增发生在许多类型的癌症中。我们已经观察到阿霉素治疗后 cyclin D1 的表达情况,以参考细胞死亡和其他可能的治疗意义。我们研究了阿霉素治疗对 HL-60 细胞的细胞周期、存活、细胞内水平(流式细胞术)、cyclin D1 的细胞内定位(荧光显微镜)和 CCND1 表达(实时 RT-PCR)的影响。用 0.15 和 0.3 μM 阿霉素处理后,cyclin D1 的荧光强度增加。实时 RT-PCR 证实了这一趋势。与 PBGD 参考基因相比,暴露于 0.15 μM 阿霉素的细胞中 CCND1 的表达增加。同时,G0/G1、S 和 G2/M 检查点的调控发生了一些变化,伴随着群体中多倍体分数的变化。在 0.3 μM 阿霉素时尤为明显,此时细胞死亡率也明显升高。总之,根据所用浓度的不同,细胞死亡和 S、G2/M 和多倍体细胞数量的变化可能与 cyclin D1 水平相对应。这反过来又可能反映了该蛋白作为可能的生存/不可逆转调节因子之一的重要作用,这取决于其浓度,在上述细胞亚群中更明显的细胞死亡背景下,这种作用似乎尤为合理。

相似文献

1
Expression of cyclin D1 after treatment with doxorubicin in the HL-60 cell line.多柔比星处理后 HL-60 细胞系中环细胞周期蛋白 D1 的表达。
Cell Biol Int. 2014 Jul;38(7):857-67. doi: 10.1002/cbin.10290. Epub 2014 May 6.
2
Expression of cyclin A, B1 and D1 after induction of cell cycle arrest in the Jurkat cell line exposed to doxorubicin.阿霉素诱导 Jurkat 细胞系细胞周期阻滞后细胞周期蛋白 A、B1 和 D1 的表达。
Cell Biol Int. 2012;36(12):1129-35. doi: 10.1042/CBI20120274.
3
Berberine inhibits cyclin D1 expression via suppressed binding of AP-1 transcription factors to CCND1 AP-1 motif.小檗碱通过抑制AP-1转录因子与CCND1 AP-1基序的结合来抑制细胞周期蛋白D1的表达。
Acta Pharmacol Sin. 2008 May;29(5):628-33. doi: 10.1111/j.1745-7254.2008.00786.x.
4
Enhanced chemosensitivity by simultaneously inhibiting cell cycle progression and promoting apoptosis of drug-resistant osteosarcoma MG63/DXR cells by targeting Cyclin D1 and Bcl-2.通过靶向细胞周期蛋白 D1 和 Bcl-2 同时抑制耐药骨肉瘤 MG63/DXR 细胞的细胞周期进程并促进其凋亡来增强化疗敏感性。
Cancer Biomark. 2012;12(4):155-67. doi: 10.3233/CBM-130305.
5
Vincristine induces cell cycle arrest and apoptosis in SH-SY5Y human neuroblastoma cells.长春新碱诱导 SH-SY5Y 人神经母细胞瘤细胞周期停滞和凋亡。
Int J Mol Med. 2013 Jan;31(1):113-9. doi: 10.3892/ijmm.2012.1167. Epub 2012 Oct 30.
6
A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells.一种合成尿嘧啶衍生物,通过降低MCF-7细胞中的细胞周期蛋白D1和细胞周期蛋白依赖性激酶1,并增加p21和p27来发挥抗肿瘤活性。
Breast Cancer Res Treat. 2007 Nov;105(3):237-46. doi: 10.1007/s10549-006-9450-2. Epub 2006 Nov 24.
7
Usnic acid inhibits growth and induces cell cycle arrest and apoptosis in human lung carcinoma A549 cells.乌苏酸抑制人肺癌 A549 细胞的生长并诱导细胞周期停滞和凋亡。
Nutr Cancer. 2013;65 Suppl 1:36-43. doi: 10.1080/01635581.2013.785007.
8
Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.槲皮素通过Wnt/β-连环蛋白信号通路抑制细胞周期蛋白D1和生存素的表达,从而抑制人SW480结肠癌的生长。
Cancer Invest. 2009 Jul;27(6):604-12. doi: 10.1080/07357900802337191.
9
An apolar extract of Critonia morifolia inhibits c-Myc, cyclin D1, Cdc25A, Cdc25B, Cdc25C and Akt and induces apoptosis.刺桐叶极性提取物抑制 c-Myc、cyclin D1、Cdc25A、Cdc25B、Cdc25C 和 Akt 并诱导细胞凋亡。
Int J Oncol. 2012 Jun;40(6):2131-9. doi: 10.3892/ijo.2012.1412. Epub 2012 Mar 23.
10
The influence of arsenic trioxide on the cell cycle, apoptosis and expression of cyclin D1 in the Jurkat cell line.三氧化二砷对Jurkat细胞系细胞周期、细胞凋亡及细胞周期蛋白D1表达的影响
Acta Histochem. 2014 Oct;116(8):1350-8. doi: 10.1016/j.acthis.2014.08.008. Epub 2014 Sep 23.

引用本文的文献

1
Temporal analysis of doxorubicin-induced cardiac toxicity and hypertrophy.阿霉素诱导的心脏毒性和肥大的时间分析。
NPJ Syst Biol Appl. 2025 Jul 1;11(1):67. doi: 10.1038/s41540-025-00545-7.
2
Macrophage induces anti-cancer drug resistance in canine mammary gland tumor spheroid.巨噬细胞诱导犬乳腺肿瘤球体中的抗癌药物耐药性。
Sci Rep. 2023 Jun 27;13(1):10394. doi: 10.1038/s41598-023-37311-w.
3
The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells.新型 HDAC6 抑制剂 MPT0G211 联合化疗药物对人急性白血病细胞的抗癌作用。
Clin Epigenetics. 2018 Dec 29;10(1):162. doi: 10.1186/s13148-018-0595-8.
4
Ginger extract adjuvant to doxorubicin in mammary carcinoma: study of some molecular mechanisms.姜提取物辅助阿霉素治疗乳腺癌:部分分子机制研究。
Eur J Nutr. 2018 Apr;57(3):981-989. doi: 10.1007/s00394-017-1382-6. Epub 2017 Feb 22.
5
A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiforme.酪氨酸激酶抑制剂克唑替尼和达沙替尼联合用于治疗多形性胶质母细胞瘤。
Oncotarget. 2015 Nov 10;6(35):37948-64. doi: 10.18632/oncotarget.5698.